Skip to main content

Table 4 Comparison of bacilli negative conversion rates of pulmonary Mycobacterium avium complex patients between the control and levofloxacin (LVFX) groups

From: Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease

Group

Follow-up period (months)

Start of treatment

1

3

6

12

Control

0/57 (0 %)

28/57 (49 %)

41/52 (79 %)

39/48 (81 %)

32/42 (76 %)

LVFX

0/18 (0 %)

5/18 (28 %)

*3/8 (38 %)

4/6 (67 %)

2/3 (67 %)

  1. If the results of both the smear and the culture examination were negative, the patients were classed as “bacilli negative conversion.” *A P-value of less than 0.05 was considered statistically significant